IndraLab

Statements


PSMD14 activates PI3K/AKT/mTOR. 2 / 2
| 2

reach
"PSMD14 may enhance tumor progression and resistance to anlotinib in osteosarcoma by regulating the PI3K/AKT/mTOR signaling pathway [32]."

reach
"These findings imply that PSMD14 may increase osteosarcoma function by stimulating the PI3K/AKT/mTOR pathway."